Breast cancer is the most common type of
cancer in women in many areas and is increasing found in developing countries, where the majority of cases are diagnosed in late stages. Retinoic
acids, through their associated
nuclear receptors, exert intoxicating effects on cell growth, differentiation and apoptosis, and hold significant promise in relation to
cancer therapy and
chemoprevention. To enhance our understanding of the molecular mechanisms associated with retinoic
acids in the
breast cancer cell line MCF-7 in a time-dependent manner, we conducted a proteomic analysis of MCF-7 cells using the 2-DE couple with high-throughput mass spectrometry and bioinformatics tools. In the 2-DE patterns of MCF-7 cells treated with
retinoic acid in a time-dependent manner, 35
protein spots were found to be differentially expressed. These were 17 increased, 4 decreased, and 14 unevenly expressed
protein spots, all of which were analyzed using LTQ-FTICR mass spectrometry. Furthermore, five candidate
proteins, up-regulated, were validated by western blotting. These were
nucleoredoxin, latexin,
aminomethyltransferase, translationally controlled one
tumor protein, and rab
GDP dissociation inhibitor β. These observations represent novel findings leading to new insight into the exact mechanism behind the effect of retinoic
acids in MCF-7 cells while also identifying possible therapeutic targets for
breast cancer diagnosis and novel
drug development paths for the treatment of this disease.